OCTOBER, 2011 Gene-Related Patent Applications Posted - Full application
CHEMISTRY: ANALYTICAL AND IMMUNOLOGICAL TESTING
Appl Number Title Assignee Date Issued Country
20110256635 SOLUBLE HUMAN ST-2 ANTIBODIES AND ASSAYS CRITICAL CARE DIAGNOSTICS, INC 20-Oct-11 United States
20110256633 Secretory Granules and Granulogenic Factors as a Target for Cancer Treatment INHA-INDUSTRY PARTNERSHIP INSTITUTE 20-Oct-11 Korea
20110262968 ANTIBODIES THAT BIND TO PSCA PROTEINS FOR DIAGNOSIS OF CANCER AGENSYS, INC. 27-Oct-11 United States
20110244471 SCREENING METHOD AND VECTOR, VECTOR LIBRARY, AND ASSAY KIT USED THEREFOR AKAHOSHI; EIICHI 6-Oct-11 Japan
20110256555 USE OF CXCR4 PROTEIN EXPRESSION ON THE SURFACE OF STEM CELLS AS A MARKER FOR TUMOR TROPIC POTENTIAL CEDARS-SINAI MEDICAL CENTER 20-Oct-11 United States
20110250686 NOVEL HEPATOCYTE-LIKE CELLS AND HEPATOBLAST-LIKE CELLS DERIVED FROM hBS CELLS CELLARTIS AB 13-Oct-11 Sweden
20110244464 IDENTIFICATION OF GENES OR POLYPEPTIDES THE EXPRESSION OF WHICH CORRELATES TO FERTILITY, OVARIAN FUNCTION AND/OR FETAL/NEWBORN VIABILITY Cibelli; Jose 6-Oct-11 United States
20110263003 Microbacterial Peptide Deformylase COUNCIL OF SCIENTIFIC AND INDUSTRIAL RESEARCH 27-Oct-11 India
20110256545 mRNA expression-based prognostic gene signature for non-small cell lung cancer Guo; Nancy Lan 20-Oct-11 United States
20110244453 SALMONELLA DETECTION ASSAY HEALTH PROTECTION AGENCY 6-Oct-11 United Kingdom
20110250592 METHODS FOR DETERMINING A PATIENT'S SUSCEPTIBILITY OF CONTRACTING A NOSOCOMIAL INFECTION AND FOR ESTABLISHING A PROGNOSIS OF THE PROGRESSION OF SEPTIC SYNDROME HOSPICES CIVILS DE LYON (HCL) 13-Oct-11 France
20110256524 RECOMBINANT ADENOVIRUS COMPRISING TISSUE-SPECIFIC PROMOTER AND TUMOR-TARGETING TRANS-SPLICING RIBOZYME AND USES THEREOF Industry-Academic Cooperation Foundation, Dankook University 20-Oct-11 United States
20110244459 METHODS FOR IDENTIFYING ERBB2 ALTERATION IN TUMORS IPSOGEN 6-Oct-11 France
20110250612 NOVEL CENTROMERIC PROTEIN SHUGOSHIN Japan Science & Technology Agency 13-Oct-11 Japan
20110244515 METHOD OF PREPARING PROTEIN HAVING HIGH CONTENT OF SPECIFIC AMINO ACID BY CO-EXPRESSION WITH TRNA OF SPECIFIC AMINO ACID Lee; Sang Yup 6-Oct-11 Korea
20110250607 YEAST-BASED METHODS OF IDENTIFYING NUCLEIC ACIDS AND COMPOUNDS FOR TREATING NEURODEGENERATIVE DISEASES Marcus; Stevan 13-Oct-11 United States
20110262978 EXPRESSION VECTOR FOR PSEUDONOCARDIA AUTOTROPHICA MERCIAN CORPORATION 27-Oct-11 Japan
20110256538 EPIGENOMIC DNA MODIFICATIONS FOR TISSUE TYPING, EARLY CANCER DETECTION, AND DISEASE MANAGEMENT Philadelphia Health & Education Corporation 20-Oct-11 United States
20110262921 Test for the Detection of Bladder Cancer Sabichi; Anita L 27-Oct-11 United States
20110250653 L-SUCCINYLAMINOACYLASE AND PROCESS FOR PRODUCING L-AMINO ACID USING IT SEKISUI MEDICAL CO., LTD. 13-Oct-11 Japan
20110244500 Gel electrophoresis method useful for resolution and characterization of nerve tissue ultra high molecular weight protein aggregates Shapiro; Howard K 6-Oct-11 United States
20110250658 Recombinant Microalgae Cells Producing Novel Oils Solazyme, Inc. 13-Oct-11 United States
20110262980 MICRO-ORGANISMS FOR THE PRODUCTION OF ACETOL OBTAINED BY A COMBINATION OF EVOLUTION AND RATIONAL DESIGN Soucaille; Philippe 27-Oct-11 France
20110256579 Method for Verifying and/or Identifying Hormonally Effective Substances TECHNISCHE UNIVERSITAET DRESDEN 20-Oct-11 Germany
20110262998 PROCESS FOR PREPARING INCLUSION BODY-FORMING PROTEIN TEIJIN PHARMA LIMITED 27-Oct-11 Japan
20110262910 MARKER FOR COLON CANCER AND METHOD FOR DETECTING COLON CANCER THE CHINESE UNIVERSITY OF HONG KONG 27-Oct-11 Hong Kong
20110244530 L-SUCCINYLAMINOACYLASE AND PROCESS FOR PRODUCING L-AMINO ACID USING IT TOYO BOSEKI KABUSHIKI KAISHA 6-Oct-11 Japan
20110244568 RNA SEQUENCE-SPECIFIC MEDIATORS OF RNA INTERFERENCE Tuschl; Thomas 6-Oct-11 Germany
20110244446 RNA SEQUENCE-SPECIFIC MEDIATORS OF RNA INTERFERENCE Tuschl; Thomas 6-Oct-11 Germany
20110256604 GENERATION OF ASPOROGENOUS SOLVENTOGENIC CLOSTRIDIA University of Delaware 20-Oct-11 United States
20110262920 METHODS FOR PREDICTING SURVIVAL IN CANCER PATIENTS Yen; Yun 27-Oct-11 United States
20110244475 MN Gene and Protein Zavada; Jan 6-Oct-11 Czech Rep.
COMBINATORIAL CHEMISTRY TECHNOLOGY
Appl Number Title Assignee Date Issued Country
20110245102 Gene Expression Profiling of EGFR Positive Cancer Baker; Joffre B 6-Oct-11 United States
20110257036 Methods and Compositions for the Diagnosis of Cancer Susceptibilities and Defective DNA Repair Mechanisms and Treatment Thereof Dana Farber Cancer Institute, Inc. 20-Oct-11 United States
20110263460 COMPOSITIONS AND METHODS FOR PRODUCING REPLICATION COMPETENT HUMAN IMMUNODEFICIENCY VIRUS (HIV) Diagnostic Hybrids, Inc. 27-Oct-11 United States
20110251087 PROGNOSTIC AND DIAGNOSTIC METHOD FOR CANCER THERAPY Glinsky; Gennadi V. 13-Oct-11 United States
20110251097 DIAGNOSTIC KIT OF COLON CANCER USING COLON CANCER RELATED MARKER AND DIAGNOSTIC METHOD THEREOF KOREA RESEARCH INSTITUTE OF BIOSCIENCE AND BIOTECHNOLOGY 13-Oct-11 Korea
20110251109 Fluidic methods for devices for parallel chemical reactions LIFE TECHNOLOGIES CORPORATION 13-Oct-11 United States
20110251081 METHODS AND COMPOSITIONS FOR DETERMINING GENE FUNCTION Microsoft Corporation 13-Oct-11 United States
20110251077 Methods and Systems for Diagnosis of Non-Central Nervous System (CNS) Diseases in CNS Samples Podhajcer; Osvaldo L. 13-Oct-11 Argentina
20110263447 METHOD FOR THE PROGNOSIS AND DIAGNOSIS OF TYPE II DIABETES IN CRITICAL PERSONS PROBIOX SA 27-Oct-11 Belgium
20110263454 Methods of Identifying Functional Characteristics of Promoters, Transcription Modifying Proteins and Transcription Modulating Agents Salk Institute for Biological Studies 27-Oct-11 United States
20110251076 NON-INVASIVE DETECTION OF FETAL GENETIC TRAITS SEQUENOM, INC. 13-Oct-11 United States
20110263444 METHOD FOR EXAMINING PROGNOSIS OF BREAST CANCER SYSMEX CORPORATION 27-Oct-11 Japan
20110251086 NEUROBLASTOMA PROGNOSTIC MULTIGENE EXPRESSION SIGNATURE Vandesompele; Joke 13-Oct-11 Belgium
DATA PROCESSING
Appl Number Title Assignee Date Issued Country
20110257896 Differential Filtering of Genetic Data AFFYMETRIX, INC 20-Oct-11 United States
20110246081 Metabolomics-Based Identification of Disease-Causing Agents GEORGIA TECH RESEARCH CORPORATION 6-Oct-11 United States
20110246080 GENE CLUSTERING PROGRAM, GENE CLUSTERING METHOD, AND GENE CLUSTER ANALYZING DEVICE SONY CORPORATION 6-Oct-11 United States
20110257888 METHOD OF DETERMINING CHRONIC FATIGUE SYNDROME SYSMEX CORPORATION 20-Oct-11 Japan
DRUG
Appl Number Title Assignee Date Issued Country
20110245320 NUCLEASE RESISTANT DOUBLE-STRANDED RIBONUCLEIC ACID ALNYLAM PHARMACEUTICALS, INC. 6-Oct-11 United States
20110251259 COMPOSITIONS AND METHODS FOR INHIBITING EXPRESSION OF CD274/PD-L1 GENE ALNYLAM PHARMACEUTICALS, INC. 13-Oct-11 United States
20110257247 Method of Treating Neurodegenerative Disease ALNYLAM PHARMACEUTICALS, INC. 20-Oct-11 United States
20110263684 Lipid Formulated Compositions and Methods for Inhibiting Expression of Serum Amyloid A Gene ALNYLAM PHARMACEUTICALS, INC. 27-Oct-11 United States
20110245329 DOUBLE-STRANDED RNA STRUCTURES AND CONSTRUCTS, AND METHODS FOR GENERATING AND USING THE SAME ALNYLAM PHARMACEUTICALS, INC. 6-Oct-11 United States
20110262481 HIGH GROWTH REASSORTANT INFLUENZA A VIRUS AVIR GREEN HILLS BIOTECHNOLOGY RESEARCH DEVELOPMENT TRADE AG 27-Oct-11 Austria
20110263683 RNA Interference Mediated Inhibition of Gene Expression Using Chemically Modified Short Interfering Nucleic Acid (siNA) Beigelman; Leonid 27-Oct-11 United States
20110245326 Post-Transcriptional Regulation Of RNA-Related Processes Using Encoded Protein-Binding RNA Aptamers Belmont; Brian J 6-Oct-11 United States
20110250233 ANTITUMOR VACCINATION USING ALLOGENEIC TUMOR CELLS EXPRESSING ALPHA (1,3)-GALACTOSYLTRANSFERASE Central Iowa Health System 13-Oct-11 United States
20110243900 SOFT TISSUE AND BONE AUGMENTATION AND BULKING UTILIZING MUSCLE-DERIVED PROGENITOR CELLS, COMPOSITIONS AND TREATMENTS THEREOF Chancellor; Michael B. 6-Oct-11 United States
20110257167 IDENTIFICATION OF LKB1 MUTATION AS A PREDICTIVE BIOMARKER FOR SENSITIVITY TO TOR KINASE INHIBITORS Chopra; Rajesh 20-Oct-11 United States
20110262480 Method for producing multiple modifications in the chromosome of gram-negative bacteria and salmonella strains which are deficient in c-di-GMP synthesis obtained by said method CONSEJO SUPERIOR DE INVESTIGATIONES CIENTIFICAS 27-Oct-11 Spain
20110262570 Transcriptional Profiling and Biomarker-Based Methods for Identifying and Evaluating Agents for Antioxidant Efficacy in Cosmetic Skin Care Formulations Finlay; Deborah Ruth 27-Oct-11 United States
20110257080 Hepatitis B Virus Compositions and Methods of Use Fox Chase Cancer Center 20-Oct-11 United States
20110243974 NOVEL TUMOR ANTIGEN PROTEIN SART-3 AND TUMOR ANTIGEN PEPTIDES THEREOF GREEN PEPTIDE CO., LTD. 6-Oct-11 Japan
20110244026 DELIVERY OF MRNA FOR THE AUGMENTATION OF PROTEINS AND ENZYMES IN HUMAN GENETIC DISEASES Guild; Braydon Charles 6-Oct-11 United States
20110257140 Biomarkers of Mineralocorticoid Receptor Activation INSERM (Institut National de la Sante et de la Rec herche Medicale) 20-Oct-11 France
20110263523 TET2 AS A NEW DIAGNOSTIC AND PRONOSTIC MARKER IN HEMATOPOIETIC NEOPLASMS INSTITUT GUSTAVE-ROUSSY 27-Oct-11 France
20110243910 MAMMALIAN RNA DEPENDENT RNA POLYMERASE JAPAN HEALTH SCIENCES FOUNDATION 6-Oct-11 Japan
20110262441 METHOD FOR SELECTIVE CONTROL OF HELPER T CELL FUNCTION Japan Science and Technology Agency 27-Oct-11 Japan
20110250258 TUMOR-SPECIFIC DELIVERY OF THERAPEUTIC AGENTS VIA LIPOSOMASE JOHNS HOPKINS UNIVERSITY 13-Oct-11 United States
20110251256 USE OF TRIM72 AS A TARGET FOR MUSCLE AND HEART ENHANCER KOREA UNIVERSITY INDUSTRIAL & ACADEMIC COLLABORATIVE FOUNDATION 13-Oct-11 Korea
20110251195 ADRB2 GENE POLYMORPHISM ASSOCIATED WITH INTRAOCULAR PRESSURE RESPONSE TO TOPICAL BETA-BLOCKERS Marshfield Clinic 13-Oct-11 United States
20110256155 METHODS TO MOLECULARLY CHARACTERIZE CIRCULATING TUMOR CELLS MEDIMMUNE, LLC 20-Oct-11 United States
20110243880 MODIFIED POLYMERS FOR DELIVERY OF POLYNUCLEOTIDES, METHOD OF MANUFACTURE, AND METHODS OF USE THEREOF Mersana Therapeutics, Inc. 6-Oct-11 United States
20110245175 INHIBITING INTERACTION BETWEEN THE HIF-1ALPHA AND p300/CBP WITH HYDROGEN BOND SURROGATE-BASED New York University 6-Oct-11 United States
20110251182 AGENTS AND METHODS FOR TREATING ISCHEMIC AND OTHER DISEASES NoNO, Inc. 13-Oct-11 Canada
20110243925 Gene Expression Profiles Being Predictive for the Response of Tumors to Pharmaceutically Effective Compounds ONCOTEST GMBH 6-Oct-11 Germany
20110263679 C12ORF48 AS A TARGET GENE FOR CANCER THERAPY AND DIAGNOSIS Oncotherapy Science, Inc. 27-Oct-11 Japan
20110243958 ANTIMICROBIAL AGENTS THAT TARGET BACTERIAL VKOR PRESIDENT AND FELLOWS OF HARVARD COLLEGE 6-Oct-11 United States
20110262399 PORPHOBILINOGEN DEAMINASE GENE THERAPY Proyecto de Biomedicina CIMA S.L. 27-Oct-11 Spain
20110262361 EFFECTIVE NEW DRUG TARGET FOR THE TREATMENT OF TUBERCULOSIS Riccardi; Giovanna 27-Oct-11 Italy
20110263687 RNA MOLECULES AND USES THEREOF RIKEN 27-Oct-11 Japan
20110251130 Methods and Compositions for Promoting Bone Growth Robertson; Stephen Peter 13-Oct-11 New Zealand
20110263680 REDUCED SIZE SELF-DELIVERING RNAI COMPOUNDS RXi Pharmaceuticals Corporation 27-Oct-11 United States
20110262437 USE OF ERBB4 AS A PROGNOSTIC AND THERAPEUTIC MARKER FOR MELANOMA Samuels; Yardena R 27-Oct-11 United States
20110262358 MOLECULAR MARKER FOR CANCER STEM CELL Sapporo Medical University 27-Oct-11 Japan
20110245145 METHODS AND REAGENTS FOR THE DIAGNOSIS, PREVENTION AND TREATMENT OF INSULIN RESISTANCE SHANGHAI INSTITUTES FOR BIOLOGICAL SCIENCES, CAS 6-Oct-11 China P. Rep.
20110243944 Fusion Protein Inhibiting Osteoclast Formation, Preparation Method and Medicine Compositions Thereof Shanghai Kexin Biotech Co., Ltd. 6-Oct-11 China P. Rep.
20110250230 CELL CAPABLE OF EXPRESSING EXOGENOUS GITR LIGAND Shiku; Hiroshi 13-Oct-11 Japan
20110263676 SMALL INTERFERING RNA FOR GENE KNOCKDOWN OF THE SUBCUTANEOUS N-METHYL-D-ASPARTATE RECEPTOR NR1 SUBUNIT, AND IT'S APPLICATION ON PHARMACEUTICS TAN; Ping-Heng 27-Oct-11 Taiwan
20110243975 TRANSFORMED SOYBEAN PLANT WHICH ACCUMULATES VACCINE, AND USE THEREOF Terakawa; Teruhiko 6-Oct-11 Japan
20110243980 METHODS AND SYSTEMS FOR O-GLYCOSYLATING PROTEINS THE GOVERNORS OF THE UNIVERSITY OF ALBERTA 6-Oct-11 Canada
20110262350 BREAST ENDOTHELIAL CELL EXPRESSION PATTERNS THE JOHNS HOPKINS UNIVERSITY 27-Oct-11 United States
20110263686 ANTISENSE OLIGONUCLEOTIDES FOR INDUCING EXON SKIPPING AND METHODS OF USE THEREOF THE UNIVERSITY OF WESTERN AUSTRALIA 27-Oct-11 Australia
20110245318 RNA SEQUENCE-SPECIFIC MEDIATORS OF RNA INTERFERENCE Tuschl; Thomas 6-Oct-11 Germany
20110256090 Method for Identifying Genes Involved in Trail-Induced Apoptosis and Therapeutic Applications Thereof UNIVERSITE DE MONTPELLIER 2 SCIENCES ET TECHNIQUES 20-Oct-11 France
20110251272 METHODS AND COMPOSITIONS FOR PREDICTING DRUG RESPONSES UNIVERSITY OF WASHINGTON 13-Oct-11 United States
20110256182 GENES ENCODING MAJOR CAPSID PROTEIN L1 OF HUMAN PAPILLOMA VIRUS Zhang; Gaoxia 20-Oct-11 China P. Rep.
FOOD OR EDIBLE MATERIAL
Appl Number Title Assignee Date Issued Country
20110256260 METHODS AND COMPOSITIONS FOR SYNTHESIS OF LONG CHAIN POLYUNSATURATD FATTY ACIDS Calgene LLC 20-Oct-11 United States
20110262591 LIPASES WITH HIGH SPECIFICITY TOWARDS SHORT CHAIN FATTY ACIDS AND USES THEREOF Laan Van Der; Jan Metske 27-Oct-11 Netherlands
IMAGE ANALYSIS
Appl Number Title Assignee Date Issued Country
20110262025 Cosmetic Compositions and Methods for Maintaining and Improving Barrier Function of the Stratum Corneum and to Reduce the Visible Signs of Aging in Skin Jarrold; Bradley Bryan 27-Oct-11 United States
MULTICELLULAR LIVING ORGANISMS
Appl Number Title Assignee Date Issued Country
20110252504 Promoter From Z. Mais BASF Plant Science GmbH 13-Oct-11 Germany
20110265226 IMPROVED PRODUCTION OF PROTEINS WITH DOWNSTREAM BOX FUSIONS IN PLASTIDS AND IN BACTERIA CORNELL UNIVERSITY 27-Oct-11 United States
20110265193 IDENTIFICATION OF MUTATION AND METHOD FOR DETECTING LAVENDER FOAL SYNDROME IN THE HORSE CORNELL UNIVERSITY 27-Oct-11 United States
20110252485 Novel gene disruptions, compositions and methods relating thereto de Sauvage; Frederic 13-Oct-11 United States
20110247100 PLANT PEPTIDE GAMMA-ZEIN FOR DELIVERY OF BIOMOLECULES INTO PLANT CELLS DOW AGROSCIENCES LLC 6-Oct-11 United States
20110252489 METHOD OF IDENTIFYING PROLIFICACY IN MAMMALS EMPRESA BRASILEIRA DE PESQUISA AGROPECUARIA-EMBRAP 13-Oct-11 Brazil
20110247090 Synthetic 5'UTRs, Expression Vectors, and Methods for Increasing Transgene Expression INTREXON CORPORATION 6-Oct-11 United States
20110252503 Plants With Improved Nitrogen Utilization and Stress Tolerance IOWA CORN PROMOTION BOARD 13-Oct-11 United States
20110252488 Method of Identifying Genes which Promote Hybrid Vigour and Hybrid Debility and Uses Thereof Kay; Peter Hamilton 13-Oct-11 Australia
20110265196 PENAEIDIN GENE PROMOTERS IN TIGER SHRIMP AND APPLICATIONS THEREOF NATIONAL TAIWAN UNIVERSITY 27-Oct-11 Taiwan
20110252486 CHONDROCYTE-LIKE CELL, AND METHOD FOR PRODUCING SAME Osaka University 13-Oct-11 Japan
20110258710 Methods of Modifying Eukaryotic Cells REGENERON PHARMACEUTICALS, INC. 20-Oct-11 United States
20110247095 METHOD OF EXPRESSION OF FOREIGN GENE IN PLANT INDUCED BY CHEMICAL SUBSTANCE Saijo; Takanori 6-Oct-11 United States
20110258740 GENES, PROTEINS AND VECTORS FOR INCREASING TOLERANCE OF PLANTS AND MICROBES TO ABIOTIC STRESSES AND THE USE THEREOF SICHUAN BIODESIGN GENE ENGINEERING CO., LTD. 20-Oct-11 China P. Rep.
20110265192 NUCLEAR RECEPTOR SENSOR SYSTEM IN TRANSGENIC ANIMAL SYDDANSK UNIVERSITET 27-Oct-11 Denmark
20110265223 FUNCTIONAL ANALYSIS OF JATROPHA CURCAS GENES TEMASEK LIFE SCIENCES LABORATORY LIMITED 27-Oct-11 Singapore
20110247088 TETRACYCLINE INDUCIBLE TRANSCRIPTION CONTROL SEQUENCE TET Systems GmbH & Co., 6-Oct-11 Germany
20110247091 Transgenic Cells and Chickens Expressing RIG-I THE GOVERNORS OF THE UNIVERSITY OF ALBERTA 6-Oct-11 Canada
20110252506 PROMOTION OF SOMATIC EMBRYOGENESIS IN PLANTS BY WUSCHEL GENE EXPRESSION THE ROCKEFELLER UNIVERSITY 13-Oct-11 United States
NATURAL RESINS OR DERIVATIVES
Appl Number Title Assignee Date Issued Country
20110251376 Mammalian Tumor Susceptibility Genes and their Uses Cohen; Stanley N. 13-Oct-11 United States
PLANT PROTECTING AND REGULATING COMPOSITIONS
Appl Number Title Assignee Date Issued Country
20110257013 METHOD FOR CONTROLLING FLOWERING TIME OF PLANT SUMITOMO CHEMICAL COMPANY, LIMITED 20-Oct-11 Japan
SURGERY
Appl Number Title Assignee Date Issued Country
20110257564 METHODS FOR THERMAL MODULATION OF NERVES CONTRIBUTING TO RENAL FUNCTION Ardian, Inc. 20-Oct-11 United States
20110257384 METHODS AND COMPOSITIONS FOR THE SPECIFIC INHIBITION OF GENE EXPRESSION BY DOUBLE-STRANDED RNA INTEGRATED DNA TECHNOLOGIES, INC. 20-Oct-11 United States
20110245482 NON-INVASIVE DETECTION OF FETAL GENETIC TRAITS SEQUENOM, INC. 6-Oct-11 Switzerland
20110263974 METHOD FOR PRESSURE MEDIATED SELECTIVE DELIVERY OF THERAPEUTIC SUBSTANCES AND CANNULA The Government of United States of America as represented by the Secretary of the Department 27-Oct-11 United States
TELEVISION
Appl Number Title Assignee Date Issued Country
20110249137 PREDETERMINED SITE LUMINESCENCE MEASURING METHOD, PREDETERMINED SITE LUMINESCENCE MEASURING APPARATUS, EXPRESSION AMOUNT MEASURING METHOD, AND MEASURING APPARATUS OLYMPUS CORPORATION 13-Oct-11 Japan
Bookmark and Share

Login



alta vista babel fish
To traslate this page, click a flag!
flag flag flag flag flag flag flag flag

Advertisements

Miracle Ear
What will your miracle sound like?
Miracle Ear Hearing Aids
Dayal Resources, Inc.
Translations from German to English, including patents, research papers, legalese and materials for publication. Dayal Resources, Inc. is your dependable resource. Please contact wdayal@dayalresources.com
Eden's Bounty Multi-SanTM
Colorless, odorless, biodegradable instant sanitizer is effective against both gram positive and gram-negative bacteria; kills in 30 seconds. Free of chlorine and quaternary ammonium compounds. EPA registered food contact surface sanitizer. Austin Davis Industries, Inc.
TERRA+ CLEAN Acid-Replacement Surface Cleaner
Safe, totally natural, 100% biodegradable, multi-functional cleaning product providing safety in the workplace for both humans and environmental surfaces - without compromising performance. Can be diluted up to 25:1. Austin Davis Industries, Inc.